Health Discovery launches MelApp for melanoma risk assessment

Health Discovery launches MelApp for melanoma risk assessment

News and Articles
Apr 21 2012

Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment is featured in this month’s Men’s Health Magazine.    

First launched last summer for iPhone, MelApp uses highly sophisticated patent protected mathematical algorithms and image based pattern recognition technology to analyze an uploaded image. The app was validated using an image database licensed from Johns Hopkins University Medical Center and uses a device’s camera feature to deliver a risk analysis of user’s photographed skin lesions within seconds. In addition, MelApp can use the smartphone’s GPS to refer users to physicians specializing in the diagnosis and treatment of melanoma for proper medical diagnosis and treatment.

“Being currently used in nearly 50 countries, and having been named one of the ‘Top 10 Apps That Could Save Your Life’ in a recent issue of Parade Magazine, MelApp has become a worldwide success,” stated Stephen D. Barnhill, M.D. Chairman and CEO of Health Discovery Corporation. “We are very proud of the fact that we continue to hear from people who have used MelApp and as a result they have made appointments with their physicians to have a proper medical examination and biopsy which led to a diagnosis of early melanoma still in the curable stage. This demonstrates the importance of MelApp in educating the public about melanoma.”

Source: Health Discovery Corporation

Source: www.news-medical.net

Rate article
Add a comment